On Balance
A series of individual stock concerns in both the US and Europe – think Glaxo Smith Kline, Moderna, Astra Zeneca, Eli Lilly, Smith and Nephew, Merck and even Novo Norsdisk added to the fact that the new Trump administration may not be friendly for the sector has seen the sector in a Trump Slump.
Investing is all about knowledge which is why we have always used the phrase “The Need to Know” when describing what Apollo is and does and h0w it can help investors. Apollo (through the EDGE platform) provides investors an insight which gives them that edge.
President Macron’s decision to call a snap election has had a dramatic effect on bond and equity markets to the extent that and even before Marine Le Pen offered a concilliatory olive branch, we were looking at some Indicators and signals coming from Apollo that might suggest some interesting investment opportunities are beginning to show […]
The consequence of recent events (SVB) meant that the market had to reconsider the discount rate being applied to future cash and the repricing meant the sector has come back to the Orange line – FV. A moment that we call ‘back to value’ – zero premium to present value so surely an opportunity to buy?